Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NovaScan Neuroimaging Clinics is a network of specialized medical facilities dedicated to brain-specific Positron Emission Tomography (PET) imaging. Established by Grey Matters Health Inc., the clinics utilize the FDA-cleared CareMiBrain™ system, a unique seated PET scanner that offers high-resolution imaging with significantly reduced radiation exposure. The clinics primarily focus on the early detection and monitoring of Alzheimer's Disease, as well as other neurodegenerative conditions such as Parkinson's and dementia. By providing dedicated neuroimaging services, NovaScan aims to support the growing clinical need for diagnostic confirmation required for new amyloid-targeting therapies like Leqembi and Kisunla. The flagship clinic is located in Davie, Florida, with plans for national expansion across the United States to address the limited availability of brain-specific PET imaging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NovaScan Neuroimaging Clinics.